Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
News
UCB's pipeline strategy in 2026: Doubling down on immunology and neurology
Discover how UCB's pipeline strategy in 2026 is still focused on its core areas of immunology and neurology. The post UCB's pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu.
Read more
Report
Seven biotechs driving progress in Duchenne muscular dystrophy
In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. The post Seven biotechs driving progress in Duchenne muscular dystrophy appeared first on Labiotech.eu. Labiotech
Read more
Report
We asked 19 biotech leaders what breaks their deals. It wasn't the science.
The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering. The post We asked 19 biotech leaders what breaks their deals. It wasn't the science. appeared first on Labiotech.eu. Labiot
Read more
Report
Top biotech deals in July 2026
The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI. The post Top biotech deals in July 2026 appeared first on Labiotech.eu. Labiotech UG and Labiotech.eu. Unauthorized use and/or du
Read more
Report
Why Western pharma is sleeping on China's circular RNA revolution
The CEO of Therorna discusses the science of behind circular RNA and why Western pharma hasn't paid enough attention to what's being built in China. The post Why Western pharma is sleeping on China's circular RNA revolution appeared first on Labiotech.eu.
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.